Revvity RVTY
NYSE RVTY
$129.72 +3.37 (+2.67%)
As of: Aug 27, 2026 · 3:59 PM EDT

Revvity (RVTY) Cash from Financing Activities (2009 - 2026)

Revvity's (RVTY) quarterly Cash from Financing Activities came in at -$88.9 million in Q2 2026, up 45.68% YoY from -$61.0 million in Q2 2025, and up 49.58% on a QoQ basis from -$176.3 million in Q4 2025.

Revvity (RVTY) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Revvity (RVTY) has 18 years of Cash from Financing Activities data on file, last reported at -$88.9 million in Q2 2026.

  • Quarterly Cash from Financing Activities rose 45.68% year-over-year to -$88.9 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$782.8 million (up 37.72% YoY) and the FY2025 annual result came in at -$857.5 million, up 23.99% from the prior year.
  • Cash from Financing Activities grew to -$88.9 million in Q2 2026, from -$176.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of -$19.6 million in Q4 2023 to a low of -$3.7 billion in Q1 2023.
  • A 5-year average of -$461.9 million and a median of -$176.3 million in 2025 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities soared 99.48% — and 2025, when it plunged 1041.63%.
  • Tracing RVTY's Cash from Financing Activities over 5 years: stood at -$164.9 million in 2022, then jumped by 88.1% to -$19.6 million in 2023, then plunged by 883.94% to -$193.0 million in 2024, then grew by 8.64% to -$176.3 million in 2025, then soared by 49.58% to -$88.9 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$88.9 million (Q2 2026), -$176.3 million (Q4 2025), and -$215.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -1.57 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 7.27 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 12.21 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -144.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -214.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -325.19 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -129.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -317.75 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -919.90 Mn
10 Revvity 14.41 Bn 13.39 Bn 416.87 Mn -23.16 Mn

Historic Data

Download Data
DateValue
Jul 5, 2026 -23.16 Mn
Jul 5, 2026 -23.16 Mn
Apr 5, 2026 -88.90 Mn
Apr 5, 2026 -88.90 Mn
Dec 28, 2025 -176.31 Mn
Dec 28, 2025 -176.31 Mn
Sep 28, 2025 -215.07 Mn
Sep 28, 2025 -215.07 Mn
Jun 29, 2025 -302.48 Mn
Jun 29, 2025 -302.48 Mn
Mar 30, 2025 -163.66 Mn
Mar 30, 2025 -163.66 Mn
Dec 29, 2024 -192.99 Mn
Dec 29, 2024 -192.99 Mn
Sep 29, 2024 -873.74 Mn
Sep 29, 2024 -873.74 Mn
Jun 30, 2024 -26.50 Mn
Jun 30, 2024 -26.50 Mn
Mar 31, 2024 -35.01 Mn
Mar 31, 2024 -35.01 Mn